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Objective: The aim of the study was to ascertain the clinical and epidemiologic characteristics of patients with 
nosocomial or community-acquired Staphylococcus aureus bacteremic pneumonia. 
Methods: A prospective study of 134 cases diagnosed between January 1990 and December 1995 was performed. 
Results: Fifty cases involved primary bacteremic pneumonias, of which 80% were nosocomial (the majority, 72%, 
in intensive care unit patients, of whom 57% were post-surgery). Of the 84 cases of secondary pneumonia, 36 were 
non-intravenous drug users (78% nosocomial, of whom 43% were in the intensive care unit), and 48 cases were 
intravenous drug users (98% community-acquired). 
Conclusions: Nosocomial S. aweus bacteremic pneumonia was especially frequent in intensive care unit patients 
(6&l%), and community-acquired pneumonia in intravenous drug users (72.3%). In non-intravenous drug users, 
clinical outcome and mortality were similar for nosocomial and community-acquired pneumonia. 
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INTRODUCTION 
Staphylococcus aureus is an important cause of severe 
pulmonary infection. I-4 Community-acquired S. aweus 
pneumonia has been reported as being associated 
with influenza,5-8 with cystic fibrosis in children9 and 
with intravenous drug use. lo-l2 Nosocomial pneumonia 
has been reported in patients with severe underlying 
illnesses,1,13 in burns unit patients,14 and, more recently, 
in patients in intensive care and receiving mechanical 
ventilation.15%16 
The clinical manifestations of staphylococcal 
pneumonia do not seem to differ from other bacterial 
etiologies. 2,17,18 They have a heterogeneous radiologic 
pattern,17-21 with frequent cavitation17,19,22 and high 
mortality.1A,17 
However, since the publication in 19195 of the first 
paper on staphylococcal pneumonia, there have been 
few prospective studies23 that have included compre- 
hensive series on this subject. In this study, we include 
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134 cases of bacteremic pneumonia caused by S. aureus 
diagnosed over a period of 6 years, with the aim of 
describing the clinical and epidemiologic characteristics 
of this infection. 
PATIENTS AND METHODS 
Hospital 
The Hospital Universitario San Carlos (HUSC) is a 
tertiary-care center with 1479 beds, serving a population 
of 570 000 inhabitants in the northwest of the Madrid 
metropolitan area. 
Microbiological methods 
Samples for microbiological diagnosis were taken using 
bronchial aspiration, bronchoalveolar lavage, and 
protected brush catheter. The Murray and Washington 
criteria24 were used to evaluate the quality of these 
samples, in order to rule out those with high levels of 
oropharyngeal contamination. We considered as signi- 
ficant for the diagnosis of pneumonia the finding of 
S. aureus in pure culture in two samples from the same 
patient taken on consecutive days. Protected brush 
catheter samples were obtained using the technique 
described by Wimberley et a1.25 We considered colony 
counts of ~10~ CFU/mL of S. aureus to be significant. 
Bronchoalveolar lavage samples were also obtained by 
bronchoscopy. When they arrived at the laboratory, a 
quantitative culture was taken,26 and an S. aureus count 
of lo5 CFU/mL was considered significant. 
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Blood cultures were processed using the BACTEC- 
NR 660 system until April 1992, and BACTEC-NR 860 
thereafter. 
Study population and design 
The study included those patients with S. aureus 
pneumonia who also met the criteria for the diagnosis 
of significant S. aureus bacteremia between 1 January 
1990 and 31 December 1995. For study purposes, 
bacteremic pneumonia was divided into three groups: 
primary pneumonia, secondary pneumonia in intra- 
venous drug users (IVDUs), and secondary pneumonia 
in non-IVDUs. A prospective evaluation was made, 
and a comparison was made of the epidemiologic and 
clinical characteristics of the patients who acquired 
pneumonia in the hospital and in the community in each 
of the three groups. 
Definition of terms 
Staphylococcal pneumonia: a diagnosis was made 
when there were symptoms of infection of the lower 
respiratory tract and pulmonary infiltrates in the chest 
X-ray not attributable to other causes, coinciding with 
the isolation of S. aureus as the only pathogen in two 
samples of bronchial aspirate taken on consecutive days 
or in one or more of the following samples: protected 
brush catheter, bronchoalveolar lavage, and/or blood 
culture. 
S. aureus bacteremia: one or more positive blood 
cultures for this microorganism. 
Bacteremic pneumonia: patient with significant 
bacteremia and pneumonia according to the above 
definitions. 
Primary pneumonia :27-30 clinical symptoms and signs 
of lower respiratory tract infection, and the isolation of 
S. aureus in respiratory samples preceding or coinciding 
with the diagnosis of staphylococcal bacteremia. 
Secondary pneumonia: when its clinical manifesta- 
tions appeared in the evolution of a patient previously 
diagnosed with S. aureus bacteremia.18 
Aspiration pneumonia was defined following the 
criteria of Finegold. 
Nosocomial pneumonia: clinical manifestations 
began within 72 h after admission to hospital, and a 
sample positive for S. aureus was taken during this 
period. 
Community-acquired pneumonia: a positive sample 
(respiratory and/or blood cultures) was obtained before 
the first 72 h after admission, and the patient had not 
been admitted in the previous 2 weeks. 
Predisposing factors: invasive procedures or treat- 
ments that favored the acquisition of infection. 
Respiratory distress: following the clinical definition 
by Kollef and Schuster.32 
Death was considered to be due to the staphylo- 
coccal infection when one or more of the following 
criteria were fulfilled: a culture which was positive 
for S. aureus at the time of death (blood culture or 
representative sample from the lower respiratory tract); 
persistent respiratory symptoms and radiologic evidence 
of the persistence of pneumonia; and death with no 
other explanation within the first 7 days after the diag- 
nosis of staphylococcal pneumonia. Deaths not explained 
by these criteria were considered to result from the 
patient’s underlying disease. 
Statistical analysis 
Analysis of the variables was carried out using the 
statistical program BMDP V7.0 for Unix. The Mann- 
Whitney test was used for comparison of the quanti- 
tative data. Qualitative variables were associated using 
the chi-square test, and when the conditions of validity 
of this test were not met, Fisher’s exact test was used. 
Results were considered statistically significant when 
PsO.05. 
RESULTS 
General data 
One hundred and thirty-four cases of bacteremic 
staphylococcal pneumonia were analyzed and classified 
as follows: primary pneumonia (50 episodes, 37.3%); 
secondary pneumonia in IVDUs (48 episodes, 35.8%); 
and secondary pneumonia in non-IVDUs (36 episodes, 
26.9%). There were 69 (51.5%) cases of nosocomial 
bacteremic pneumonia (68.1% in intensive care units 
(ICUs)) and 65 (48.5%) cases of community-acquired 
bacteremic pneumonia (72.3% IVDUs). 
Primary pneumonia 
Of the 50 cases of primary pneumonia, 40 (80%) were 
nosocomial, and 10 (20%) community-acquired. 
There were significant differences between patients 
with nosocomial primary pneumonia and those with 
community-acquired primary pneumonia with regard to 
methicillin-resistant Staphylococcus aureus (MRSA) 
infection, area of admission, age, length of hospital stay, 
and the following predisposing factors: history of food 
aspiration, previous stay in the ICU, previous surgery, 
previous intubation, and insertion of a nasogastric 
tube. Table 1 shows a comparison of the age, area of 
admission and predisposing factors for infection in 
patients with primary pneumonia acquired both in the 
community and in the hospital. 
The most frequent underlying diseases in patients 
with nosocomial and community-acquired primary 
bacteremic pneumonia are shown in Table 2. 
With regard to complications, no significant differ- 
ences were found between patients with nosocomial 
pneumonia and those with community-acquired pneu- 
monia (Table 2). 
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Table I. Age, area of admission and predisposing factors of patients with nosocomial or community-acquired bacteremic primary 
pneumonia 
Nosocomial primary 
pneumonia 
(n=40) 
Community-acquired 
primary pneumonia 
(n= 10) P-value 
MRSA pneumonia 
Age (average) 
Hospital stay (average) 
Area of admission 
KU and post-surgical recovery 
Internal medicine 
Surgery 
Predisposing factors 
Antibiotics/predisposing factors 
Previous pneumonia 
Neutropenia 
Aspiration 
Previous KU stay 
lntubation 
Nasogastric tube 
Altered mental state 
Previous surgery 
Dialysis 
Transfusion 
19 (47.5%) 2(20%) 0.16 
56.4k23.7 74.8k18.8 0.03 
37.9224.9 19.3a9.5 0.01 
29 (72.5%) 
8 (20%) 
3 (7.5%) 
1 (10%) 
9 (90%) 
0 
<O.Ol 
-co.01 
1 
9 (22.5%) 
4 (10%) 
: (10%) 
31 (77.5%) 
31 (77.5%) 
34(85%) 
35 (87.5%) 
23 (57.5%) 
2 (5%) 
7 (17.5%) 
1 (10%) 
0 
1 (10%) 
8 (80%) 
0 
0 
1 (10%) 
5 (50%) 
0 
0 
0 
1 
0.79 
0.2 
<O.Ol 
<O.Ol 
10.01 
10.01 
0.01 
<O.Ol 
1 
0.3 
MRSA. methicillin-resistant S. aureus. 
Table 2. Underlying diseases and clinical outcome of patients with nosocomial or community-acquired bacteremic primary 
pneumonia 
Nosocomial primary 
pneumonia 
(n=40) 
Community-acquired 
primary pneumonia 
(n= 10) P-value 
Underlying diseases 
Underlying diseases (average) 
Lung diseases 
Diabetes mellitus 
Heart disease 
Vascular disease 
Liver disease 
Neoplasia 
Cerebrovascular accident 
Arterial hypertension 
Chronic renal insufficiency 
Clinical outcome 
Respiratory distress 
Septic shock 
DIC 
Neurologic alterations 
Mortality due to infection 
1.5k1.2 
7 (17.5%) 
5 (12.5%) 
5 (12.5%) 
2(5%) 
4(10%) 
7 (17.5%) 
10(25%) 
7 (17.5%) 
2 (5%) 
15 (37.5%) 
16(40%) 
2(5%) 
7 (17.5%) 
21 (52.5%) 
1.7k0.6 0.6 
1 (10%) 1 
1 (10%) 1 
2 (20%) 1 
0 1 
0 0.79 
1 (10%) 1 
3 (30%) 1 
2(20%) 1 
0 1 
4(40%) 
3(30%) 
0 
1 (10%) 
3(30%) 
1 
1 
1 
1 
0.29 
DIG, disseminated intravascular coagulation. 
Mortality due to the staphylococcal infection was 
48%, and was higher in the group of patients with 
nosocomially acquired pneumonia than in patients with 
community-acquired pneumonia (52.5% versus 30%; 
P=O.29). 
methicillin-susceptible S. aureus, and pneumonia with a 
nodular image on the upper left lobe. Treatment was 
begun with vancomycin; the patient improved, and, after 
10 days of treatment, he requested voluntary discharge. 
Secondary pneumonia 
Secondary pneumonia in IVDUs. Of the 84 cases of 
secondary pneumonia studied, 48 (57.1%) involved 
IVDUs. Of these, 47 (97.9%) acquired the infection 
in the community, and only one patient had secondary 
nosocomial pneumonia. This was a 22-year-old male 
who was admitted with deep venous thrombosis 
and who, at 10 days, developed bacteremia due to 
Community-acquired secondary pneumonia in IVDUs. 
This infection affected young people, mainly men, and 
was due to MRSA in four patients (8.5%). In addition 
to intravenous drug use, the predisposing factors for 
infection (Table 3) were previous infection (25.5%), 
previous pneumonia (10.6%), or previous antibiotic 
treatment (17%). 
With regard to underlying diseases (Table 3), of the 
47 patients studied, 35 (74.5%) had HIV infection. 
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Table 3. Secondary pneumonia in intravenous drug users 
(IVDUs) 
Community-acquired secondary 
pneumonia in IVDUs (n=47) 
MRSA infection 
Age (average) 
Internal medicine 
Predisposing factors 
Previous infection 
Previous antibiotherapy 
Previous pneumonia 
Neutropenia 
Alcoholism 
Endovascular catheter 
Underlying diseases 
HIV infection 
Liver disease 
Clinical outcome 
Respiratory distress 
Septic shock 
DIC 
Neurologic alterations 
Mortality due to infection 
4 (8.5%) 
27.224 
47 (100%) 
12 (25.5%) 
8(17%) 
5 (10.6%) 
1 (2.1%) 
2 (4.2%) 
2 (4.2%) 
35 (74.5%) 
4 (8.5%) 
3 (6.4%) 
9 (19.1%) 
5 (10.6%) 
4 (8.5%) 
9 (19.1%) 
MRSA, methicillin-resistant S. aureus; HIV, human immunodeficiency 
virus; DIC, disseminated intravascular coagulation. 
The complications suffered by these patients are 
shown in Table 3. Mortality due to infection was lower 
than in the other groups studied (19.1%). 
Secondary pneumonia in non-IVDUs 
Of the 36 non-IVDU cases with secondary pneumonia, 
28 (77.8%) were nosocomial in origin and eight (22.2%) 
were community-acquired. 
We found 69 cases (51.5%) of nosocomial pneu- 
monia (58% primary) and 65 (48.5%) community- 
acquired cases (15.3% primary). The proportion of 
nosocomial pneumonia would increase to 79% if 
we excluded IVDUs. These data agree with the 
literature.1,2$20 
In the group of patients with nosocomial pneu- The patients with community-acquired pneumonia 
monia, a higher proportion of the infections was due to included in our analysis fall into the following groups: 
MRSA, infection was especially frequent in the ICU, 
and the patients had a higher average age. Table 4 shows 
and compares the predisposing factors for both groups 
of patients. 
Among patients with nosocomial pneumonia, 11 
(39.3%) had lung diseases, and 11(39.3%) had neoplasia. 
In the case of patients with community-acquired pneu- 
monia, the most common underlying condition was 
neoplasia (37.5%). 
With regard to complications, there was no signi- 
ficant difference between nosocomial and community- 
acquired infections (Table 5). 
Mortality due to staphylococcal infection was 47.2%, 
and was higher in patients with nosocomial pneumonia 
than in patients with community-acquired pneumonia 
(53.6% versus 25%, P=O.24). 
DISCUSSION 
S. aureus pneumonia is a clinical entity with high 
morbidity and mortality. 1-4~17 Together with endovascular 
catheters and cutaneous infection, it is reported to 
be one of the most common portals of entry for 
bacteremia,29,33 and it appears frequently as a secondary 
or metastatic infection.28,33 
Table 4. Age, area of admission and predisposing factors for infection in non-IVDU patients with nosocomial or community-acquired 
pneumonia 
Nosocomial secondary 
pneumonia in 
non-IVDUs (n=28) 
Community-acquired 
secondary pneumonia 
in non-IVDUs (n=8) P-value 
MRSA pneumonia 
Age (average) 
Hospital stay (average) 
Area of admission 
ICU and post-surgical recovery 
Internal medicine 
Surgery 
Predisposing factors 
Previous antibiotherapy 
Previous pneumonia 
Neutropenia 
Aspiration 
Previous ICU stay 
lntubation 
Nasogastric tube 
Altered mental state 
Previous surgery 
Chemotherapy 
Dialysis 
Transfusion 
Central catheter 
Urinary catheter 
11 (39.3%) 0 
65.8?16 49.82273 
39.8227.1 28.8224.1 
12 (42.9%) 
13 (46.4%) 
3 (10.7%) 
: (100%) 
0 
6 (21.4%) 
i (10.7%) 
1 (3.6%) 
16 (57.1%) 
1 (12.5%) 
1 (12.5%) 
I ii2.5sj 
0 
0 
0 
0 
1 (12.5%) 
0 
3 (37.5%) 
1 (12.5%) 
: (50%) 
1 (12.5%) 
17 (60.7%) 
16 (57.1%) 
10 i35.7sj 
14 (50%) 
7(25%) 
0 
14 (50%) 
24 (85.7%) 
23 (82.1%) 
0.07 
0.12 
0.20 
0.03 
0.01 
1 
0.22 
1 
-co.01 
<O.Ol 
co.01 
0.38 
0.01 
0.65 
0.22 
0.01 
0.05 
<O.Ol 
MRSA, methicillin-resistant 5. aureus; KU, intensive care unit. 
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Table 5. Underlying diseases and clinical outcome of non-IVDU patients with community-acquired or nosocomial pneumonia 
Underlying diseases 
Underlying diseases (average) 
Lung diseases 
Diabetes mellitus 
Heart diseases 
Vascular diseases 
Liver diseases 
Neoplasias 
Cerebrovascular accident 
Arterial hypertension 
Chronic renal insufficiency 
Clinical outcome 
Respiratory distress 
Septic shock 
DIC 
Neurologic alterations 
Mortality due to infection 
Nosocomial secondary 
pneumonia in 
non-IVDUs (n=28) 
2.421.2 
11 (39.3%) 
3 (10.7%) 
11 (39.3%) 
3 (10.7%) 
3 (10.7%) 
11 (39.3%) 
5 (17.9%) 
8 (28.6%) 
1 (3.6%) 
8 (28.6%) 
11 (39.3%) 
0 
6 (21.4%) 
15 (53.6%) 
Community-acquired 
secondary pneumonia 
in non-IVDlJs (n=8) 
1.6kl.l 
1 (12.5%) 
1 (12.5%) 
1 (12.5%) 
0 
3” (37.5%) 
1 (12.5%) 
1 (12.5%) 
1 (12.5%) 
3 (37.5%) 
2(25%) 
0 
2 (25%) 
2 (25%) 
P-value 
0.12 
0.22 
1 
0.22 
1 
1 
1 
1 
0.64 
0.4 
0.67 
0.68 
1 
0.24 
DIC, disseminated intravascular coagulation. 
(1) IVDUs with pneumonia probably caused by septic 
emboli (72.3%); (2) patients with secondary pneumonia 
and severe underlying illnesses (15.3%), mainly 
neoplasia and chronic renal insufficiency; and (3) elderly 
patients with altered mental states and aspiration 
pneumonia (12.3%). In this sense, we differ on several 
points from the study by Woodhead et a1,34 which 
reviewed 61 cases of community-acquired staphylococcal 
pneumonia. The authors found that a high percentage 
of their patients suffered from chronic conditions (lung 
diseases), and that influenza virus infection was an 
important factor associated with pneumonia. We did not 
find any cases associated with the influenza virus. We can 
attribute this difference to greater use of the influenza 
vaccine in certain population groups (elderly and 
chronically ill patients), and to the generalized use of 
antibiotics in the treatment of community-acquired 
respiratory processes. On the other hand, the number of 
cases of staphylococcal pneumonia associated with the 
influenza virus reported by Woodhead et al and other 
previous studies could be skewed by imprecise diag- 
nostic considerations. 
Most of our patients with community-acquired 
pneumonia were IVDUs (72.3%), and they had 
pneumonia with a favorable clinical outcome. Of the 
IVDU group, the majority (93.6%) had septic emboli 
as a result of tricuspid endocarditis. This has been 
previously reported by other authors.10-12 It is interest- 
ing that four of these patients (8.5%) were infected by 
MRSA. This could lead us to consider this population as 
a route for disseminating this microorganism in the 
community, as described by Saravolatz in 1987.35 On 
the other hand, half of our group of aged patients with 
community-acquired aspiration pneumonia suffered 
from an altered mental state. None of these patients 
came from a nursing home. The greatest frequency of 
community-acquired staphylococcal pneumonia has 
been reported among patients who live in these 
centers.20,36-38 However, given our results, we consider 
advanced age and associated characteristics (altered 
mental state in most cases) as the determining risk factor 
in this group regardless of whether the infection was 
acquired in these centers. 
As was the case with other authors,1,2J7,20.21,39 we 
can also state that S. aureus pneumonia is mainly 
nosocomial. In general, most of our patients developed 
pneumonia in the ICU (72.5% of primary nosocomial 
cases and 42.8% of secondary cases in non-IVDU 
nosocomial patients). Another risk group comprised 
elderly patients with a high number of underlying 
illnesses, mainly pulmonary illnesses or neoplasia. These 
patients were especially prone to secondary pneumonia, 
and represented 26% of all cases of nosocomially- 
acquired pneumonia. The remaining patients (7.3%) 
were over 85 years of age, with altered mental status and 
aspiration pneumonia during their stay in hospital for 
other reasons. 
At present, nosocomial staphylococcal pneumonia 
is reported in ICU patients, patients undergoing 
intubation and mechanical ventilation, very often 
in young people with multiple traumas, and especially 
in post-surgical patients. Our study agrees with these 
reports; 59.4% of all cases of nosocomial pneumonia 
developed in the ICU, and 68.1% had a previous stay in 
the ICU, although not all of them developed the 
infection in this area. This figure is greater than that 
found in the study by Musher et a1.2 The many studies 
on ICU pneumonia in recent years reveal the importance 
of the role of S. uureus.15J6,40-42 
The clinical manifestations of staphylococcal pneu- 
monia2J7,21 do not seem to differ from other bacterial 
etiologies. There can be a fulminant and acute course in 
some caseszo and a subacute course in others.43,44 Our 
patients generally presented acute clinical forms, and a 
frequency of complications similar to that reported for 
pneumonia due to Gram-negative bacilli.39 
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In our study, we found a high frequency of MRSA 
pneumonia (26%), but this varied according to the 
groups studied, in such a way that the greatest pro- 
portion of MRSA pneumonia was found in nosocomial 
primary pneumonia (47.5%), followed by nosocomial 
secondary pneumonia in non-IVDUs (39.3%). In 
community-acquired primary pneumonia the frequency 
was 20%, and in secondary pneumonia in IVDUs it 
was 8.3%. The frequency of MRSA pneumonia varies 
from study to study, according to the population groups 
analyzed.2,20 In general, MRSA pneumonia is nosocomial 
in origin,3s,13 and there are no extensive studies (few 
large series of patients) clarifying its incidence in the 
community.44 However, some community-acquired 
cases are included in series of staphylococcal pneu- 
monia,13 in many cases associated with infections in 
nursing homes37 or community-acquired MRSA 
bacteremia in IVDUS.~~,~~ 
The mortality due to staphylococcal pneumonia in 
the pre-antibiotic era varied between 50% and 90%.sz46 
Despite adequate antibiotic therapy, mortality is still 
high, at around 30-50%. 1-4~17 In our study, we found a 
high mortality rate (48% in primary pneumonia, and 
47.2% in non-IVDU secondary pneumonia), except in 
drug users (19.1%). These figures are closer to those 
for pneumonia caused by Gram-negative bacilli, and 
are greater than those for pneumonia caused by other 
Gram-positive microorganisms.39 
CONCLUSION 
In our study population, staphylococcal pneumonia 
appeared as a severe infection, frequently associated 
with clinical complications and a high mortality rate. 
Nosocomial S. UZOYUS bacteremic pneumonia was 
frequently due to MRSA, and was especially frequent in 
ICUs. Most of our patients with community-acquired 
pneumonia were IVDUs. 
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